Tyra Biosciences Inc
General ticker "TYRA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $906.9M
Tyra Biosciences Inc follows the US Stock Market performance with the rate: 30.9%.
Estimated limits based on current volatility of 2.8%: low 13.80$, high 14.60$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.39$, 17.00$]
- 2024-12-30 to 2025-12-30 estimated range: [8.18$, 16.59$]
Financial Metrics affecting the TYRA estimates:
- Negative: Non-GAAP EPS, $ of -1.61 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -8.24 <= 2.35
- Negative: negative Net income
- Positive: -3.48 < Investing cash flow per share, $ of -3.39
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term TYRA quotes
Long-term TYRA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $26.29MM | $58.93MM | $79.94MM |
| Operating Income | $-26.29MM | $-58.93MM | $-79.94MM |
| Non-Operating Income | $-0.01MM | $3.60MM | $10.81MM |
| R&D Expense | $20.64MM | $43.01MM | $62.52MM |
| Income(Loss) | $-26.29MM | $-55.33MM | $-69.13MM |
| Profit(Loss) | $-26.29MM | $-55.33MM | $-69.13MM |
| Stockholders Equity | $301.74MM | $257.83MM | $204.26MM |
| Assets | $306.70MM | $266.18MM | $225.86MM |
| Operating Cash Flow | $-23.75MM | $-50.28MM | $-50.14MM |
| Capital expenditure | $0.66MM | $0.56MM | $0.77MM |
| Investing Cash Flow | $-0.65MM | $-0.56MM | $-144.60MM |
| Financing Cash Flow | $311.35MM | $0.63MM | $1.54MM |
| Earnings Per Share* | $-0.63 | $-1.23 | $-1.62 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.